Keros Therapeutics, Inc. Uncategorized Contracts & Agreements

14 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Letter Agreement, dated April 17, 2025, by and between the Company and Pontifax
Keros Therapeutics, Inc.
Biotechnology
2025
Rights Agreement, dated as of April 9, 2025 between Keros Therapeutics, Inc. and Computershare Trust Company, N.A., which includes the form of Certificate of Designation as...
Keros Therapeutics, Inc.
Biotechnology
2025
Description of the Registrant's Securities
Keros Therapeutics, Inc.
Biotechnology
2025
Description of the Registrants Securities
Keros Therapeutics, Inc.
Biotechnology
2024
Amendment No
Keros Therapeutics, Inc.
Biotechnology
2024
Description of the Registrants Securities
Keros Therapeutics, Inc.
Biotechnology
2023
Amendment to Offer Letter, dated August 1, 2022, between Jennifer Lachey and the Registrant
Keros Therapeutics, Inc.
Biotechnology
2022
Description of the Registrants Securities
Keros Therapeutics, Inc.
Biotechnology
2022
Description of
Keros Therapeutics, Inc.
Biotechnology
2021
Form of Indemnity Agreement between the registrant and its directors and officers
Keros Therapeutics, Inc.
Biotechnology
DE
2020
Offer Letter Agreement by and between the registrant and Keith Regnante, dated as of February 7, 2020
Keros Therapeutics, Inc.
Biotechnology
2020
Offer Letter Agreement by and between the registrant and Claudia Ordonez, dated as of August 20, 2019
Keros Therapeutics, Inc.
Biotechnology
2020
Offer Letter Agreement by and between the registrant and Jenn Lachey, dated as of April 20, 2016
Keros Therapeutics, Inc.
Biotechnology
2020
Offer Letter Agreement by and between the registrant and Jasbir Seehra, dated as of December 14, 2015
Keros Therapeutics, Inc.
Biotechnology
2020